{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:32:44Z","timestamp":1791059564089,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.vaccine.2011.01.113","type":"journal-article","created":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T17:58:43Z","timestamp":1297879123000},"page":"2968-2977","source":"Crossref","is-referenced-by-count":63,"title":["Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice"],"prefix":"10.1016","volume":"29","author":[{"given":"Krishnamurthy","family":"Konduru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven B.","family":"Bradfute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohanraj","family":"Manangeeswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siham","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufi","family":"Morshed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo G.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.01.113_bib0005","series-title":"Fields Virology","first-page":"1409","article-title":"Filoviridae: Marburg and Ebola viruses","author":"Sanchez","year":"2007"},{"key":"10.1016\/j.vaccine.2011.01.113_bib0010","doi-asserted-by":"crossref","unstructured":"Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S, Reeder SA, et al. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog 2008;4(November (11)):e1000212.","DOI":"10.1371\/journal.ppat.1000212"},{"issue":"January (5913)","key":"10.1016\/j.vaccine.2011.01.113_bib0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1126\/science.323.5913.451a","article-title":"Emerging infectious diseases Scientists puzzle over Ebola-Reston virus in pigs","volume":"323","author":"Normile","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.01.113_bib0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0065-3527(05)64011-0","article-title":"Polymorphism of filovirus glycoproteins","volume":"64","author":"Volchkov","year":"2005","journal-title":"Adv Virus Res"},{"issue":"December (Pt 12)","key":"10.1016\/j.vaccine.2011.01.113_bib0025","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1099\/0022-1317-82-12-2839","article-title":"Biosynthesis and role of filoviral glycoproteins","volume":"82","author":"Feldmann","year":"2001","journal-title":"J Gen Virol"},{"issue":"December (26)","key":"10.1016\/j.vaccine.2011.01.113_bib0030","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1073\/pnas.94.26.14764","article-title":"A system for functional analysis of Ebola virus glycoprotein","volume":"94","author":"Takada","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.01.113_bib0035","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1073\/pnas.95.10.5762","article-title":"Processing of the Ebola virus glycoprotein by the proprotein convertase furin","volume":"95","author":"Volchkov","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"December (24)","key":"10.1016\/j.vaccine.2011.01.113_bib0040","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1128\/JVI.76.24.12463-12472.2002","article-title":"Covalent modifications of the ebola virus glycoprotein","volume":"76","author":"Jeffers","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.01.113_bib0045","first-page":"1","article-title":"Classification, structure, and replication of filoviruses","volume":"235","author":"Feldmann","year":"1999","journal-title":"Curr Top Microbiol Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.01.113_bib0050","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"Sullivan","year":"2006","journal-title":"PLoS Med"},{"issue":"August (6949)","key":"10.1016\/j.vaccine.2011.01.113_bib0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"issue":"November (6812)","key":"10.1016\/j.vaccine.2011.01.113_bib0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.01.113_bib0065","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/JVI.00105-07","article-title":"Successful topical respiratory tract immunization of primates against Ebola virus","volume":"81","author":"Bukreyev","year":"2007","journal-title":"J Virol"},{"issue":"November (1)","key":"10.1016\/j.vaccine.2011.01.113_bib0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/viro.1998.9367","article-title":"Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates","volume":"251","author":"Hevey","year":"1998","journal-title":"Virology"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.01.113_bib0075","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.01.113_bib0080","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2011.01.113_bib0085","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1128\/JVI.00074-09","article-title":"Replication-deficient ebolavirus as a vaccine candidate","volume":"83","author":"Halfmann","year":"2009","journal-title":"J Virol"},{"issue":"December (26)","key":"10.1016\/j.vaccine.2011.01.113_bib0090","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1073\/pnas.2237038100","article-title":"Ebola virus-like particles protect from lethal Ebola virus infection","volume":"100","author":"Warfield","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"November (196 Suppl)","key":"10.1016\/j.vaccine.2011.01.113_bib0095","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"2","author":"Warfield","year":"2007","journal-title":"J Infect Dis"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.01.113_bib0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-1702(02)00338-6","article-title":"Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs","volume":"92","author":"Mellquist-Riemenschneider","year":"2003","journal-title":"Virus Res"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2011.01.113_bib0105","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.vaccine.2008.11.083","article-title":"Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"issue":"November\u2013December (3\u20134)","key":"10.1016\/j.vaccine.2011.01.113_bib0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s002620050418","article-title":"Increased potency of Fc-receptor-targeted antigens","volume":"45","author":"Guyre","year":"1997","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2011.01.113_bib0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1742-4690-4-33","article-title":"Immunogenicity of the outer domain of a HIV-1 clade C gp120","volume":"4","author":"Chen","year":"2007","journal-title":"Retrovirology"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.01.113_bib0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/JVI.75.2.717-725.2001","article-title":"Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1","volume":"75","author":"Silberstein","year":"2001","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.01.113_bib0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","article-title":"Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter","volume":"73","author":"Buchholz","year":"1999","journal-title":"J Virol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.01.113_bib0130","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/78654","article-title":"Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury","volume":"6","author":"Yang","year":"2000","journal-title":"Nat Med"},{"issue":"March (5458)","key":"10.1016\/j.vaccine.2011.01.113_bib0135","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"Wilson","year":"2000","journal-title":"Science"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.01.113_bib0140","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jmb.2007.10.017","article-title":"Complex of a protective antibody with its Ebola virus GP peptide epitope: unusual features of a V lambda x light chain","volume":"375","author":"Lee","year":"2008","journal-title":"J Mol Biol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.01.113_bib0145","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":"Lawson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.01.113_bib0150","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J Virol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.01.113_bib0155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.01.113_bib0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4049\/jimmunol.0901231","article-title":"Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis","volume":"184","author":"Bradfute","year":"2010","journal-title":"J Immunol"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2011.01.113_bib0165","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1016\/j.vaccine.2004.01.063","article-title":"Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection","volume":"22","author":"Warfield","year":"2004","journal-title":"Vaccine"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2011.01.113_bib0170","doi-asserted-by":"crossref","first-page":"14189","DOI":"10.1128\/JVI.79.22.14189-14196.2005","article-title":"Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins","volume":"79","author":"Olinger","year":"2005","journal-title":"J Virol"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2011.01.113_bib0175","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.175.2.1184","article-title":"Induction of humoral and CD8+T cell responses are required for protection against lethal Ebola virus infection","volume":"175","author":"Warfield","year":"2005","journal-title":"J Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.01.113_bib0180","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0167-7799(96)80921-8","article-title":"Immunoadhesins: principles and applications","volume":"14","author":"Chamow","year":"1996","journal-title":"Trends Biotechnol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2011.01.113_bib0185","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JVI.02151-09","article-title":"Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity","volume":"84","author":"Hood","year":"2010","journal-title":"J Virol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.01.113_bib0190","doi-asserted-by":"crossref","first-page":"8907","DOI":"10.1128\/JVI.73.10.8907-8912.1999","article-title":"Mutational analysis of the putative fusion domain of Ebola virus glycoprotein","volume":"73","author":"Ito","year":"1999","journal-title":"J Virol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.01.113_bib0195","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1128\/JVI.75.3.1576-1580.2001","article-title":"Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies","volume":"75","author":"Ito","year":"2001","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.01.113_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001121","article-title":"Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner","volume":"6.","author":"Nanbo","year":"2010","journal-title":"PLoS Pathog"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.01.113_bib0205","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/JVI.77.2.1069-1074.2003","article-title":"Identification of protective epitopes on ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses","volume":"77","author":"Takada","year":"2003","journal-title":"J Virol"},{"issue":"December (52)","key":"10.1016\/j.vaccine.2011.01.113_bib0210","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2008.09.082","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses","volume":"26","author":"Geisbert","year":"2008","journal-title":"Vaccine"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.01.113_bib0215","article-title":"Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates","volume":"4","author":"Geisbert","year":"2008","journal-title":"PLoS Pathog"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.01.113_bib0220","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/JVI.00456-08","article-title":"Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates","volume":"82","author":"Geisbert","year":"2008","journal-title":"J Virol"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2011.01.113_bib0225","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","article-title":"Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus","volume":"83","author":"Geisbert","year":"2009","journal-title":"J Virol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.01.113_bib0230","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3201\/eid1607.100159","article-title":"Postexposure treatment of Marburg virus infection","volume":"16","author":"Geisbert","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2011.01.113_bib0235","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1128\/JVI.00959-06","article-title":"Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine","volume":"80","author":"Daddario-DiCaprio","year":"2006","journal-title":"J Virol"},{"issue":"April (9520)","key":"10.1016\/j.vaccine.2011.01.113_bib0240","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment","volume":"367","author":"Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.01.113_bib0245","article-title":"Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species","volume":"6","author":"Hensley","year":"2010","journal-title":"PLoS Pathog"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2011.01.113_bib0250","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/viro.1997.8883","article-title":"Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants","volume":"239","author":"Hevey","year":"1997","journal-title":"Virology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1100185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1100185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T16:20:49Z","timestamp":1592324449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1100185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":50,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0264410X1100185X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.01.113","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}